The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial

发表于 2026-7-24 09:42:17

期刊：Nature Medicine

文献作者：Catherine J. Mummery; Arthur J. Mayorga; Adam Simmons; Tiffany W. Chow; Brady Burgess; Tuan Nguyen; Jingjing Gao; Balasubrahmanyam Budda; Lovingly Quitania Park; Ruchi Gupta; Caiyan Li; Li Shi; Sara Kenkare-Mitra; Arnon Rosenthal; Robert Paul; Michael Ward; Derk D. Purcell; Stephen Salloway; Michael Grundman; Gary Romano; Giacomo Salvadore

出版日期：2026-5-

DOI号：10.1038/s41591-026-04273-1

下载链接：https://www.nature.com/articles/s41591-026-04273-1.pdf

文献链接：https://doi.org/10.1038/s41591-026-04273-1

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

发表于 2026-7-24 09:42:18

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Nature] The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Nature] The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial 一键复制

已采纳